Disease X: A Looming Threat Deadlier Than Covid?

Disease X

Source image: google.com

Disease X: A Looming Threat Deadlier Than Covid?

As the Covid-19 pandemic wanes, healthcare professionals worldwide are turning their attention to a new and ominous menace—Disease X. Dame Kate Bingham, the former chair of the UK’s Vaccine Taskforce, has issued a stark warning, suggesting that Disease X could potentially claim 20 times more lives than its predecessor. This alarming prediction, combined with the cryptic name, has led to increased anxiety within the global health community.

What Is Disease X?

Disease X is a term coined by the World Health Organization (WHO) to describe a hypothetical pathogen, either known or unknown, capable of triggering a large-scale, severe pandemic with widespread human disease. Dr. Neha Rastogi, a Consultant in infectious diseases at Fortis Memorial Research Institute in Gurugram, explains, “Disease X is possibly and plausibly caused by a ‘pathogen X.’ It could be related to a zoonotic disease, likely an RNA virus, emerging from an environment where the epidemiological triad favors sustained transmission. These emerging or re-emerging pathogens can be labeled as X and pose a threat that necessitates intense and ongoing active surveillance and monitoring.”

There is also speculation about Disease X being an engineered pandemic pathogen, resulting from laboratory accidents or acts of bioterrorism. Such a scenario could potentially lead to catastrophic global consequences.

Prevention and Preparedness

Dr. Rastogi emphasizes that containment and mitigation strategies are essential to combat Disease X effectively. This includes the development and implementation of international guidelines to control bioterrorism and immediate, stringent travel restrictions and airport screening to contain the spread of pathogen X across borders. Global leaders, scientists, epidemiologists, and infectious disease experts must collaborate to investigate, control, and eliminate Disease X. Widespread testing, surveillance, and aggressive contact tracing are crucial tools to promptly contain potential outbreaks.

Furthermore, there should be concentrated efforts to accelerate access to essential medical resources such as test kits, vaccines, and first aid before and during the pandemic. Continuous research into preventive measures, vaccine development, and processes should be a top priority to mitigate the severe consequences of Disease X.

Dr. Rastogi advocates for a One Health approach, which aims to bridge institutional gaps, identify priority risk pathogens, and emphasize mitigation strategies for emerging and re-emerging pathogens like Disease X. This approach, involving coordination across various sectors, is crucial to preventing global catastrophes.

Comparing Disease X to Covid-19

Disease X is not a virus that we can point to with certainty; rather, it represents a looming threat that demands our attention and preparedness. Dame Kate Bingham’s warning about Disease X being potentially 20 times deadlier than Covid-19 is a cause for concern. Covid-19 has already claimed nearly seven million lives worldwide, and its impact has been significant.

While Covid-19 has been a global health crisis, Disease X could potentially surpass it in terms of devastation. Disease X’s hypothetical characteristics, as described by Bingham, are alarming. She envisions Disease X as being as infectious as measles while having a fatality rate akin to Ebola (67 percent). In essence, Disease X is a lethal combination of contagiousness and deadliness, making it a formidable adversary.

The Urgency of Preparedness

The need to prepare for Disease X is urgent. With no approved vaccine available, scientists and researchers must work diligently to develop a collection of prototype vaccines targeting various virus families. Dame Kate Bingham underscores the importance of allocating adequate financial resources for this endeavor. The cost of inaction, she warns, could be staggering. Even Covid-19, considered milder in comparison to Disease X, left a bill of $16 trillion in lost output and public health expenditure.

In conclusion, Disease X looms on the horizon as a potential pandemic deadlier than Covid-19. While it remains a hypothetical threat, the global health community must take it seriously, prioritize preparedness, and allocate resources to mitigate its impact. Disease X serves as a stark reminder of the need for international collaboration, research, and vigilance in our ongoing battle against emerging infectious diseases.